REGENERON PHARMACEUTICALS, INC. Other Inventory, Net of Reserves
REGENERON PHARMACEUTICALS, INC. (REGN) had Other Inventory, Net of Reserves of $820.90 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative
us-gaap:OtherInventoryNetOfReserves · last filed 2026-07-30
- 2026-06-30: Other Inventory, Net of Reserves $820.90M.
- 2026-03-31: Other Inventory, Net of Reserves $787.90M.
- 2025-12-31: Other Inventory, Net of Reserves $727.50M.
- 2025-09-30: Other Inventory, Net of Reserves $808.80M.
| Period end | Other Inventory, Net of Reserves | Other Inventory, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $820.90M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $787.90M 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $727.50M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $808.80M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $764.40M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $773.90M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $725.70M 10-K · filed 2026-02-04 | |
| 2024-09-30 | $766.70M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $720.70M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $611.50M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $522.10M 10-K · filed 2025-02-05 | |
| 2023-09-30 | $536.60M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $499.50M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $555.10M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $521.80M 10-K · filed 2024-02-05 | |
| 2022-09-30 | $592.80M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $623.90M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $525.80M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $448.50M 10-K · filed 2023-02-06 | |
| 2021-09-30 | $503.70M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $535.00M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $499.40M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $430.90M 10-K · filed 2022-02-07 | |
| 2020-09-30 | $553.70M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $505.70M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $481.40M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $400.90M 10-K · filed 2021-02-08 | |
| 2019-09-30 | $432.40M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $390.30M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $364.30M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $328.90M 10-K · filed 2020-02-07 | |
| 2018-09-30 | $358.94M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $295.69M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $221.62M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $212.30M 10-K · filed 2019-02-07 | $212.26M 10-K · filed 2018-02-08 |
| 2017-09-30 | $213.15M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $188.31M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $145.21M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $91.43M 10-K · filed 2018-02-08 | |
| 2016-09-30 | $74.90M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $61.81M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $45.96M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $36.16M 10-K · filed 2017-02-09 | |
| 2015-09-30 | $32.56M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $29.21M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $28.83M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $33.65M 10-K · filed 2016-02-11 | |
| 2014-09-30 | $27.81M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $27.35M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $18.66M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $11.01M 10-K · filed 2015-02-12 | |
| 2013-09-30 | $10.91M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $6.77M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $6.21M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $6.55M 10-K · filed 2014-02-13 | |
| 2011-12-31 | $1.96M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |